Re: “Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause” [Eur. J. Obstet. Gynecol. Reprod. Biol. 213 (2017) 39–44

Abstract

Listen

Translate article

We read with interest the recent study by Behnia-Willison and colleagues [ [1] Behnia-Willison F. Sarraf S. Miller J. Mohamadi B. Care A.S. Lam A. et al. Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol. 2017; 213: 39-46 Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar ] in your June issue, reporting their investigation of “the safety, feasibility and long-term efficacy (12–24 months) of fractional micro-ablative CO2 treatment in a cohort of postmenopausal women suffering dyspareunia and/or other symptoms due to GSM [genitourinary syndrome of menopause]”. Their study included 102 postmenopausal women (median age 61 years; range: 51–86) who had three fractional CO2 vaginal laser treatments at intervals of six or more weeks because they “were not responding or not able to take conventional treatments (such as œstrogen therapy for postmenopausal women).” Each woman had a colposcopy before laser treatment to grade the vaginal atrophy. Before and after the treatment, the women completed the Australian Pelvic Floor Questionnaire [ [2] Baessler K. O’Neill S.M. Maher C.F. Battistutta D. Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20: 149-158 Crossref PubMed Scopus (64) Google Scholar ]. All variables improved significantly, including sexual function, painful intercourse, vaginal dryness, and reduced libido. Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopauseEuropean Journal of Obstetrics and Gynecology and Reproductive BiologyVol. 213PreviewTo evaluate the safety and long-term efficacy of fractional CO2 laser treatment in reducing the severity of symptoms of genitourinary syndrome of menopause (GSM) in menopausal women. Full-Text PDF